REQUEST A DEMO
Total
USD $0.00
Search more companies

Mb Bioksa (Lithuania)

Main Activities: Residential Building Construction | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Secondary Activities: Water Supply and Irrigation Systems | New Housing For-Sale Builders | Industrial Building Construction | Scientific Research and Development Services
Full name: Mb Bioksa Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Mb Bioksa is an enterprise based in Lithuania. Its main office is in Rietavas. It operates in the Residential Building Construction industry. Mb Bioksa was incorporated on January 28, 2019. Mb Bioksa currently employs 5 (2025) people. The latest financial highlights indicate a net sales revenue drop of 1.52% in 2024. The enterprise’s net profit margin increased by 0.61% in 2024.

Headquarters
Naujoji g. 2
Rietavas; Telsiai county; Postal Code: LT-90311

Contact Details: Purchase the Mb Bioksa report to view the information.

Basic Information
Total Employees:
Purchase the Mb Bioksa report to view the information.
Financial Auditors:
Purchase the Mb Bioksa report to view the information.
Incorporation Date:
January 28, 2019
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Mb Bioksa report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-1.52%
Total operating revenue
-1.52%
Net Profit (Loss) for the Period
4.88%
Total equity
28.82%
Net Profit Margin
0.61%
Return on Equity (ROE)
-5.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?